Regenerative medicine: challenges and opportunities
- 6 June 2020
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 395 (10239), 1746-1747
- https://doi.org/10.1016/s0140-6736(20)31250-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical TrialsPublished by American Medical Association (AMA) ,2020
- Defining predatory journals: no peer review, no pointNature, 2020
- Downgrading of regulation in regenerative medicineScience, 2019
- Ethical development of stem-cell-based interventionsNature Medicine, 2019
- Characteristics and Scope of Training of Clinicians Participating in the US Direct-to-Consumer Marketplace for Unproven Stem Cell InterventionsJAMA, 2019
- Regenerative medicine curriculum for next-generation physiciansnpj Regenerative Medicine, 2019
- Cell and Gene Therapy Trials: Are We Facing an ‘Evidence Crisis’?eClinicalMedicine, 2019
- Bridging stem cell research and medicine: a learning health systemRegenerative Medicine, 2018
- Lancet Commission: Stem cells and regenerative medicineThe Lancet, 2018
- Approving a Problematic Muscular Dystrophy DrugJAMA, 2016